Company Filing History:
1 out of 2 
1 out of 2 Years Active: 2022
Title: Yanwei Liu: Innovator in Brain Glioma Treatment
Introduction
Yanwei Liu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medicine, particularly in the treatment of brain gliomas. His innovative work focuses on developing drugs that target specific types of brain tumors, enhancing treatment precision for patients.
Latest Patents
Yanwei Liu holds 1 patent related to his research. The patent, titled "Uses of compound in preparation of drugs for treating brain glioma," outlines the application of a compound represented by formula A in the preparation of drugs aimed at treating brain glioma, specifically glioblastoma. This invention provides a method for typing brain glioblastoma, allowing for tailored drug administration to specific patient groups, thereby facilitating precise treatment.
Career Highlights
Throughout his career, Yanwei Liu has worked with notable organizations, including Beijing Pearl Biotechnology Limited Liability Company and Beijing Neurosurgical Institute. His experience in these institutions has contributed to his expertise in the field of biotechnology and neurosurgery.
Collaborations
Yanwei Liu has collaborated with esteemed colleagues, including Ning Zhang and Huimin Hu. Their joint efforts have further advanced research and development in the treatment of brain tumors.
Conclusion
Yanwei Liu's innovative contributions to the treatment of brain gliomas highlight his dedication to improving patient outcomes through targeted therapies. His work continues to inspire advancements in medical research and drug development.